Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02901821 · ClinicalTrials.gov registry record
Predicting Concussion Outcomes With Salivary miRNA
A clinical trial of Concussion, Mild, sponsored by Milton S. Hershey Medical Center.
- Active
- Registry status
- 700
- Enrollment target
- 1
- Study location
NCT02901821: Active study of Concussion, Mild, sponsored by Milton S. Hershey Medical Center.
NCT02901821 is a study of Concussion, Mild that is active but no longer recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 700 participants, above the 165-participant average among 18 other Concussion, Mild trials with a reported enrollment target (324% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02901821, a study of Concussion, Mild, is active but no longer recruiting, sponsored by Milton S. Hershey Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify changes in salivary ribosomal nucleic acid (RNA) expression that are predictive of symptom duration and character following mild traumatic brain injury (mTBI) in children.
Primary Outcome
subjective (score \>7 on PCSI) or objective (score outside 85 percentile on accelerometer balance testing or cognitive testing)
Conditions Studied
Interventions
- GENETIC salivary RNA collection
Study Locations (1)
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2016-01 |
| Est. Completion | 2026-06 |
What the registry record for NCT02901821 still lists
NCT02901821 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 165-participant average among 18 other Concussion, Mild trials with a reported enrollment target (324% higher).
The record links to 1 condition, with Concussion, Mild appearing as the primary indexed condition, and to 1 intervention - of which salivary RNA collection is the first listed.
NCT02901821 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02901821 about?
NCT02901821 is a clinical study titled "Predicting Concussion Outcomes With Salivary miRNA". The purpose of this study is to identify changes in salivary ribosomal nucleic acid (RNA) expression that are predictive of symptom duration and character following mild traumatic brain injury (mTBI) in children.
What is the current status of trial NCT02901821?
This trial is currently active not recruiting. The enrollment target is 700 participants. The study started on 2016-01. Estimated completion is 2026-06.
What conditions does trial NCT02901821 study?
This clinical trial studies the following conditions: Concussion, Mild.
What interventions are being tested in trial NCT02901821?
The interventions under investigation include: salivary RNA collection (GENETIC).
Who is sponsoring clinical trial NCT02901821?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02901821 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Concussion, Mild
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02901821's enrollment target sits among peer trials
700 2nd of 18 the highest of 18 other Concussion, Mild trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Concussion, Mild trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE) RCT
RECRUITING · NA
-
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
RECRUITING · NA
-
BCAAs in Concussion 2.0
RECRUITING · Phase 2
-
Facilitating Access to Specialty Treatment
RECRUITING · NA
-
Concussion Treatment in Older Adults
RECRUITING · NA
-
Poly-omic Predictors of Symptom Duration and Recovery for Adolescent Concussion
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia